About MorphoSys AG

Company Description

MorphoSys is a commercial-stage biopharmaceutical company dedicated to the discovery, development, and delivery of innovative cancer medicines.

Our ambition is to redefine how cancer is treated. As a commercial-stage biopharmaceutical company, we are driven by the urgency to deliver groundbreaking medicines, aspiring to give more life for people with cancer.

Year founded

1992

Served area

Worldwide

Headcount

732

Headquarters

Semmelweisstr. 7, 82152 Planegg – Germany

Publications

Insider Trades

Date Trading entity / Person Association Trade type Volume Average price
30.11.22 Reissner, Thomas Supervisory board Buy 4,186.00 € 30.11.22
30.11.22 Reissner, Thomas Supervisory board Buy 2,698.00 € 30.11.22
30.11.22 Reissner, Thomas Supervisory board Buy 7,479.00 € 30.11.22
30.11.22 Reissner, Thomas Supervisory board Buy 13,800.00 € 30.11.22
29.11.22 Reissner, Thomas Supervisory board Buy 5,000.00 € 29.11.22
29.11.22 Reissner, Thomas Supervisory board Buy 8,100.00 € 29.11.22
28.11.22 Vermeylen, Krisja Supervisory board Buy 14,860.00 € 28.11.22
21.11.22 Cluzel, Dr. Marc Supervisory board Buy 29,922.20 € 21.11.22
11.01.22 C&F Consulting EURL Close relation Buy 46,088.85 € 11.01.22
30.07.21 Peter, Rene Other Buy 380.00 € 30.07.21
30.07.21 Vermeylen, Krisja Supervisory board Buy 16,538.66 € 30.07.21

Shareholder information

Shares outstanding

34,231,943

IPO

March 9, 1999

Stock exchange(s)

Frankfurt Stock Exchange

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.